Neurocompute scores biomedical literature, surfaces overlooked patterns, and turns Parkinson’s research into a living discovery terminal.
E grade · PMID 42021158
View analysis →E grade · PMID 42010912
View analysis →E grade · PMID 41987492
View analysis →E grade · PMID 41957973
View analysis →E grade · PMID 41952388
View analysis →E grade · PMID 41967380
View analysis →E grade · PMID 42043474
View analysis →E grade · PMID 42001887
View analysis →E grade · PMID 41975301
View analysis →E grade · PMID 42010133
View analysis →Clinical observational study reporting prevalence and risk factors for falls in older adults with Parkinson's disease at a Malaysian tertiary centre; no abstract or mechanistic/therapeutic data available.
Helpful for clinical management, fall-prevention strategies, and designing trial endpoints or stratification, but offers little direct insight or actionable leads for Parkinson's therapeutic discovery.
A brief comment on a case-control study about burning mouth syndrome prevalence in Parkinson's disease that presents no new data, mechanisms, or therapeutic insights.
Low translational value for Parkinson's drug discovery—may modestly inform symptom recognition and symptomatic care but offers no actionable pathways, biomarkers, or repurposing leads.
A short reply discussing virtual reality perspectives on freezing of gait in Parkinson's disease, likely a conceptual/commentary piece rather than new experimental data.
Low direct value for therapeutic discovery or molecular targets but may modestly inform symptomatic rehabilitation approaches and experimental designs for FOG interventions.
A national survey documenting rehabilitation service gaps and unmet needs across disability stages in Parkinson's disease.
Useful for informing clinical care delivery and prioritizing non-pharmacological interventions but offers minimal direct mechanistic or therapeutic-discovery insights for drug development.
Clinical report of necrotic skin ulcers occurring after dose escalation of subcutaneous apomorphine infusion in Parkinson's disease patients.
Relevant for safety, tolerability, and delivery-route considerations (impacting adherence and the need for alternative formulations or skin-management strategies) but offers little mechanistic insight or direct therapeutic-discovery value.
This clinical/methodological paper examines how choice of measurement instruments affects assessment of sexual dysfunction in women with Parkinson's disease.
Low direct relevance to therapeutic discovery (no mechanisms or targets), but useful for improving clinical assessment, patient-reported outcomes, and trial endpoint selection for symptomatic care.
An observational clinical study examining associations between lower-extremity dexterity and fall risk, fear of falling, and walking ability in people with Parkinson's disease.
Findings can inform rehabilitation and fall-prevention strategies with clinical relevance but offer minimal actionable mechanistic insight or direct value for therapeutic drug discovery.
A brief commentary advocating expansion of Parkinson's research collaboration into Latin America with no abstract or mechanistic/experimental data presented.
Direct therapeutic discovery value is low, but fostering regional collaboration could indirectly accelerate cohort building, data sharing, and trial recruitment that enable future translational PD studies.
This study assesses the psychometric properties of the Turkish version of the PDQoL-7 questionnaire in older adults.
It improves patient-reported outcome measurement and could aid clinical assessment or trial endpoint selection in Turkish-speaking populations, but provides negligible direct insight for therapeutic discovery or mechanistic targets.
Post-commercialization, observational data from two movement-disorder clinics reporting on inhaled levodopa as a rapid rescue therapy for Parkinson's patients with motor fluctuations, focusing on real-world efficacy, tolerability, and practical use.
Provides useful translational/clinical evidence supporting inhaled levodopa for rapid OFF-episode relief and implementation in practice, aiding symptomatic treatment decisions though it does not advance disease-modifying mechanisms.
A systematic review and meta-analysis evaluating the efficacy and safety of MRI‑guided focused ultrasound lesioning to reduce tremor in patients with tremor‑dominant Parkinson disease.
This paper is clinically relevant and translational—summarizing evidence for a non‑pharmacologic, device‑based symptomatic therapy that can inform patient selection, safety profiles, and trial design—though it offers limited insight into disease‑modifying mechanisms.
A conceptual/refinement paper examining the link between JAK2-associated clonal hematopoiesis (CHIP) and parkinsonism, emphasizing phenotypic specificity, causal inference, and how the association should be framed.
If the JAK2-CHIP–parkinsonism link is real, it highlights a potentially actionable immune/hematopoietic mechanism (and biomarkers) that could inform repurposing of JAK-pathway interventions, but the missing abstract and likely conceptual nature limit immediate translational impact.
This correction refers to a scoping review of AI-enabled wearable technologies for assessing motor function and delivering rehabilitation in Parkinson disease.
While not providing mechanistic or therapeutic targets, the review is moderately valuable for Parkinson's therapeutic development because validated wearable-derived digital biomarkers and AI-driven monitoring/rehabilitation can improve patient phenotyping, clinical trial endpoints, and remote…
Not AI summarized yet.
Pending deeper interpretation.
Not AI summarized yet.
Pending deeper interpretation.
Not AI summarized yet.
Pending deeper interpretation.
Not AI summarized yet.
Pending deeper interpretation.
Not AI summarized yet.
Pending deeper interpretation.
Not AI summarized yet.
Pending deeper interpretation.
Not AI summarized yet.
Pending deeper interpretation.
